Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource-Reference-Cited by-同舟云学术

Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource

Published:2021-05-07 Issue:8 Volume:36 Page:1795-1804
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Iwaki Hirotaka¹²³^ORCID,Leonard Hampton L.¹²³,Makarious Mary B.³,Bookman Matt⁴,Landin Barry⁵,Vismer David⁵,Casey Bradford⁶,Gibbs J. Raphael³,Hernandez Dena G.³,Blauwendraat Cornelis³,Vitale Daniel¹²³,Song Yeajin¹²³,Kumar Dinesh⁷,Dalgard Clifton L.⁸⁹,Sadeghi Mahdiar⁷¹⁰,Dong Xianjun¹¹,Misquitta Leonie¹²,Scholz Sonja W.¹³¹⁴^ORCID,Scherzer Clemens R.¹¹,Nalls Mike A.¹²³,Biswas Shameek¹⁵,Singleton Andrew B.²³, , ,

Affiliation:

1. Data Tecnica International Glen Echo Maryland USA

2. Center for Alzheimer's and Related Dementias National Institute on Aging Bethesda Maryland USA

3. Laboratory of Neurogenetics National Institute on Aging Bethesda Maryland USA

4. Verily Life Sciences San Jose California USA

5. Technome Herndon Virginia USA

6. The Michael J. Fox Foundation for Parkinson's Research New York New York USA

7. Sanofi Framingham Massachusetts USA

8. Department of Anatomy, Physiology & Genetics Uniformed Services University of the Health Sciences Bethesda Maryland USA

9. The American Genome Center Uniformed Services University of the Health Sciences Bethesda Maryland USA

10. Northeastern University Boston Massachusetts USA

11. Harvard Medical School Brigham and Women's Hospital Boston Massachusetts USA

12. Publicis Sapient Bethesda Maryland USA

13. National Institute of Neurological Disorders and Stroke Bethesda Maryland USA

14. Department of Neurology Johns Hopkins University Baltimore Maryland USA

15. Bristol Myers Squibb Seattle Washington USA

Funder

National Institutes of Health

National Institute of Neurological Disorders and Stroke

Michael J. Fox Foundation for Parkinson's Research

Celgene

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28549

Reference23 articles.

1. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

2. Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms

3. Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts

4. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval

5. Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials;Journal of Parkinson's Disease;2024-09-03

2. Loss-of-function variants in ITSN1 confer high risk of Parkinson’s disease;npj Parkinson's Disease;2024-08-15

3. Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis;npj Parkinson's Disease;2024-08-05

4. Haploinsufficiency ofITSN1is associated with Parkinson’s disease;2024-07-27

5. LRRK2-Associated Parkinsonism With and WithoutIn VivoEvidence of Alpha-Synuclein Aggregates;2024-07-22